When it comes to Covid-19 vaccines, a lot of attention seems to have centred on the ones being made in the West. So it may come as a surprise that Russia is fifth on the list of vaccine makers with the most doses under contract through pre-purchase agreements, according to Bloomberg’s Covid-19 vaccine tracker.

The shot — whimsically named Sputnik V and developed by the Gamaleya institute — is just behind GlaxoSmithKline and Sanofi’s candidate in the rankings and ahead of the shots developed by Moderna and Johnson & Johnson. This is notable for a vaccine that has yet to be featured in any peer-reviewed scientific journal...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.